This is the text extract for 2010-01 Schedule Dispatch, browse documents here.

---

17 December 2009

January 2010 Pharmaceutical Schedule Dispatch

This document is provided to pharmacists as an early notification of the changes to be announced in the January 2010 Update to the Pharmaceutical Schedule. Please notify PHARMAC (0800 66 00 50) to change or remove your contact details.

New listings  Mesalazine (Asamax) tab EC 500 mg (p’code 2288443)  Pindolol (Apo-Pindolol) tab 5 mg (p’code 748366), 10 mg (p’code 748358) and 15 mg (p’code 748374)  Silver sulphadiazine (Flamazine) crm 1% - up to 250 g available on a PSO and not in combination (p’code 2343851)  Solifenacin succinate (Vesicare) tab 5 mg (p’code 2208385) and 10 mg (p’code 2208393) – Special Authority – Retail pharmacy  Flucloxacillin sodium (AFT) cap 250 mg (p’code 2335573) and 500 mg (p’code 2224186)  Paracetamol with codeine (ParaCode) tab paracetamol 500 mg with codeine phosphate 8 mg (p’code 2344580) Changes to restrictions  Somatropin (Genotropin) inj cartridge 16 iu per vial and 36 iu per vial – amended chemical name from growth hormone biosynthetic human  Somatropin (Norditropin SimpleXx) inj 5 mg, 10 mg and 15 mg – amended chemical name from recombinant human growth hormone  Cyclosporin (Neoral) cap 25 mg, 50 mg, 100 mg and oral liq 100 mg per ml – amended chemical name from cyclosporin A  Oral feed 1.5 kcal/ml (Ensure Plus) liquid (coffee latte) – Special Authority – amended presentation Increased subsidy

Chemical Glycerol Folic acid Medroxyprogesterone acetate Pethidine hydrochloride Phenobarbitone Presentation Suppos 3.6 g Tab 0.8 mg and 5 mg Tab 2.5 mg Tab 50 mg and 100 mg Tab 15 mg and 30 mg Fully brands subsidised

PSM Apo-Folic Acid Provera PSM PSM

Deleted: 2 Deleted: 2

A327390 Page 1 of 2

---

Decreased subsidy

Chemical Metformin hydrochloride Cholecalciferol Hydrocortisone butyrate Presentation Tab immediate-release 500 mg and 850 mg Tab 1.25 mg (50,000 iu) Lipocream 0.1% 30 g OP and 100 g OP Oint 0.1%, 100 g OP Milky emul 0.1%, 100 ml OP Scalp lotn 0.1%, 100 ml OP Crm 1% and oint 1%, 15 g OP Crm 0.1 % and oint 0.1 %; 15 g OP and 45 g OP Tab 2 mg with ethinyloestradiol 35 µg and 7 inert tablets Tab 5 mg, 10 mg, 100 mg and 200 mg Inj 150 mg per ml, 1 ml Inj cartridge 16 iu per vial and 36 iu per vial Tab 0.5 mg, 2 and 8 tab pack Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml and grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml Inj phosphate 150 mg per ml, 4 ml Tab 100 mg Tab 200 mg Tab 15 mg, 30 mg and 60 mg Tab 250 µg, 500 µg and 1 mg Tab 5 mg Inj 1 mg for ECP Cap 25 mg, 50 mg, and 100 mg, and oral liq 100 mg per ml Fully brands subsidised Partially brands subsidised

Arrow-Metformin Apotex* Cal-d-Forte Locoid Lipocream Locoid Locoid Crelo Locoid Pimafucort Elocon m-Mometasone* Ginet 84* Provera Depo Provera Genotropin Dostinex, Arrow-Cabergoline* Curam* Augmentin Estelle 35-ED

Hydrocortisone with natamycin and neomycin Mometasone furorate Cyproterone acetate ethinyloestradiol with

Medroxyprogesterone acetate

Somatropin Cabergoline Amoxycillin clavulanate

Clindamycin Isoniazid Etidronate disodium Codeine phosphate Alprazolam Dexamphetamine sulphate Oxaliplatin Cyclosporin

Dalacin C PSM Etidrate PSM Arrow-Alprazolam PSM Baxter Neoral Didronel

*Indicates no change in price or subsidy is occurring to that brand from 1 January 2010

Sumatriptan changes for 1 February 2010

The Arrow-Sumatriptan brand of sumatriptan 50 mg and 100 mg tablets will be listed in 100-tablet packs from 1 February 2010. The price and subsidy of Arrow-Sumatriptan 50 mg 2-tablet and 100 mg 4-tablet packs will reduce to match the per tablet price of these strengths in the 100-tablet packs. The subsidy for all other currently listed brands and pack sizes of sumatriptan tablets will reduce to match the tablet price of Arrow-Sumatriptan tab 50 mg and tab 100 mg in the 100 packs from 1 February 2010.

Deleted: 2 Deleted: 2

A327390 Page 2 of 2